Deoxycytidine protects normal bone marrow progenitors against Ara-C and gemcitabine cytotoxicity without compromising their activity against cisplatin-resistant human ovarian cancer cells-Reference-Cited by-同舟云学术

Deoxycytidine protects normal bone marrow progenitors against Ara-C and gemcitabine cytotoxicity without compromising their activity against cisplatin-resistant human ovarian cancer cells

Published:1992-04 Issue:1 Volume:45 Page:32-39
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Bhalla Kapil,Holladay Charles,Lutzky Jose,Ibrado Ana Maria,Bullock Gloria,Jasiok Michelle,Singh Shivendra

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Oncology

Reference45 articles.

1. Ovarian carcinoma: The role of chemotherapy;Thigpen;Semin. Oncol. Suppl. 3,1988

2. Second line platinum therapy in patients with ovarian cancer previously treated with cisplatin;Markman;J. Clin. Oncol.,1991

3. Intraperitoneal cisplatin and cytarbine in the treatment of refractory or recurrent ovarian carcinoma;Markman;J. Clin. Oncol.,1991

4. Kinetics and mechanism of the 1-β-d-arabinofuranosylctyosine induced potentiation of cis-diammine-dichloroplatinum (II) cytotoxicity;Vadi;Cancer Res.,1986

5. synergistic effect of combined intraperitoneal cisplatin and cytosine arabinoside in a murine ovarian cancer model;Berek;Obstet. Gynecol.,1989

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Degradation of DAXX by adenovirus type 12 E1B-55K circumvents chemoresistance of ovarian cancer to cisplatin;Virology;2018-08

2. Abrogation of constitutive Stat3 activity circumvents cisplatin resistant ovarian cancer;Cancer Letters;2013-12

3. Radiosensitivity in Multidrug-Resistant and Cisplatin-Resistant Human Carcinoma Cell Lines;American Journal of Clinical Oncology;2003-08

4. Delayed Addition of Deoxycytidine Protects Normal CD34 + Cells against Cytotoxicity of Gemcitabine without Compromising Its Activity against Human Leukemic Cells;STEM CELLS;2003-05

5. Molecular determinants of epothilone B derivative (BMS 247550) and Apo-2L/TRAIL-induced apoptosis of human ovarian cancer cells;Gynecologic Oncology;2003-04